贲门癌胰脾联合切除的临床价值  

Clinical Value of Combined Resection of Pancreas and Spleen in Cardiac Cancer

作　　者：黄景陶[1] 赵锡江[2] 

机构地区：[1]大连大学附属新华医院胸外科,116021 [2]天津肿瘤医院

出　　处：《天津医药》2006年第6期381-383,共3页Tianjin Medical Journal

摘　　要：目的:探讨贲门癌根治术中胰脾联合切除的临床价值。方法:随机抽取贲门癌根治术217例,按术式不同分为3组,单纯贲门切除组125例,联合胰脾切除组82例,联合脾切除组10例,统计有关临床资料,研究联合胰、脾切除的利弊。结果:联合胰、脾切除组手术时间较长,但住院时间差异无统计学意义;胰、脾转移率分别为<7.4%及1%;联合胰脾切除对第10、11组淋巴结的清除有显著影响;Ⅲ期患者胰脾联合切除组的生存率稍高,而Ⅳ期患者无联合切除组生存率稍高,但差异无统计学意义。结论:贲门癌胰脾联合切除安全可行,有利于第10、11组淋巴结的清除,但以切除胰、脾转移为目的的常规胰脾联合切除是不必要的。Objective： To analyze the clinical value of combined resection of pancreas and spleen in cardiac cancer. Methods： Two hundreds and seventeen cases of surgical resection of cardiac cancer were randomly selected and divided into three groups including simple cardiac resection group （125 cases）, combined pancreas and spleen resection group （82 cases） and combined spleen resection group （10 cases）, The concerned data were recorded, and the merits and demerits of combined pancreas and spleen resection were discussed. Results： The operation time of combined pancreas and spleen resection group was longer than those of the other two groups, and there was no significant difference among three groups. The metastasis rate of pancreas and spleen was 〈7.4% and 1% respectively. There was a significant influence of combined pancreas and spleen resection on dissection of group 10 and 11 lymph nodes. The survival rates were higher in combined resection group for stage m cases and in uncombined resection group for stage IV cases, and there was no significant difference between two groups. Conclusion： Combined resection of pancreas and spleen is a safe procedure and is benefit for dissection of group 10 and 11 lymph nodes, and routine procedure for metastases resection is not necessary.

关 键 词：贲门 癌 胰腺 脾 外科手术 

分 类 号：R735.2[医药卫生—肿瘤] R657.3[医药卫生—临床医学]